BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 19, Issue 42
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (9766)
All Articles published online
The chart showing PDF series, HTML series, Tables (1-2) series.
Item 
Count 
PDF974
HTML6322
Tables (1-2)148
 Sum=7444
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1247
Download1075
 Sum=2322
Nov 14, 2013 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M. Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver. World J Gastroenterol 2013; 19(42): 7327-7340 [PMID: 24259964 DOI: 10.3748/wjg.v19.i42.7327]
URL: https://www.wjgnet.com/1007-9327/full/v19/i42/7327.htm
Number Citing Articles
1
Lauren E. Veit, Louise Maranda, Benjamin Udoka Nwosu. The nondietary determinants of vitamin D status in pediatric inflammatory bowel disease. Nutrition 2015; 31(7-8): 994 doi: 10.1016/j.nut.2015.03.010
2
Nastaran Rahimi, Mahsa Hassanipour, Narges Sistany Allahabadi, Fatemeh Sabbaghziarani, Maryam Yazdanparast, Ahmadreza Dehpour. Cirrhosis induced by bile duct ligation alleviates acetic acid intestinal damages in rats: Involvements of nitrergic and opioidergic systems. Pharmacological Reports 2018; 70(3): 426 doi: 10.1016/j.pharep.2017.11.010
3
Katharina Stratmann, Songül Aydolmus, Wenyi Gu, Dominik Heling, Ulrich Spengler, Birgit Terjung, Christian P. Strassburg, Richard Vollenberg, Irina Blumenstein, Jonel Trebicka. Hepatobiliary manifestations in patients with ulcerative colitis: a retrospective analysis. Frontiers in Medicine 2024; 10 doi: 10.3389/fmed.2023.1273797
4
Qinmei Li, Yao Cui, Baichang Xu, Yuhan Wang, Feifei Lv, Zheng Li, Huan Li, Xiaogang Chen, Xiaomin Peng, Yating Chen, Enyun Wu, Dongshuai Qu, Yichen Jian, Hongbin Si. Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner. Pharmacological Research 2021; 170: 105694 doi: 10.1016/j.phrs.2021.105694
5
Henrique C. Rocha, Eduardo G. Vilela. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases. Gastroenterología y Hepatología (English Edition) 2022; 45(2): 83 doi: 10.1016/j.gastre.2021.03.011
6
My-Linh Tran-Minh, Paula Sousa, Marianne Maillet, Matthieu Allez, Jean-Marc Gornet. Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease. World Journal of Hepatology 2017; 9(13): 613-626 doi: 10.4254/wjh.v9.i13.613
7
Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach. Gastroenterology Insights 2022; 14(1): 13 doi: 10.3390/gastroent14010002
8
Kwang Il Seo, Sang-Bum Kang. Hepatobiliary Manifestation of Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 2019; 73(5): 248 doi: 10.4166/kjg.2019.73.5.248
9
Cristina Bezzio, Cristina Della Corte, Marta Vernero, Imma Di Luna, Gianpiero Manes, Simone Saibeni. Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations. Therapeutic Advances in Gastroenterology 2022; 15: 175628482211153 doi: 10.1177/17562848221115312
10
Vanessa Mateus, João Rocha, Paula Alves, Hélder Mota-Filipe, Bruno Sepodes, Rui Pinto. Thiadiazolidinone-8 Ameliorates Inflammation Associated with Experimental Colitis in Mice. Pharmacology 2018; 101(1-2): 35 doi: 10.1159/000471808
11
Ripalta Colìa, Addolorata Corrado, Francesco Paolo Cantatore. Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases. Annals of Medicine 2016; 48(8): 577 doi: 10.1080/07853890.2016.1195011
12
Richard Conway, Candice Low, Robert J. Coughlan, Martin J. O’Donnell, John J. Carey. Risk of liver injury among methotrexate users: A meta-analysis of randomised controlled trials. Seminars in Arthritis and Rheumatism 2015; 45(2): 156 doi: 10.1016/j.semarthrit.2015.05.003
13
Keisuke Kakisaka, Kazuyuki Ishida, Kojiro Kataoka, Yuji Suzuki, Shunichi Yanai, Hidekatsu Kuroda, Tamotsu Sugai, Takayuki Matsumoto, Yasuhiro Takikawa. Reversible sclerosing cholangitis with ulcerative colitis. Pathology International 2016; 66(7): 404 doi: 10.1111/pin.12427
14
Lawrence J. Saubermann, Mark Deneau, Richard A. Falcone, Karen F. Murray, Sabina Ali, Rohit Kohli, Udeme D. Ekong, Pamela L. Valentino, Andrew B. Grossman, Elizabeth B. Rand, Maureen M. Jonas, Shehzad A. Saeed, Binita M. Kamath. Hepatic Issues and Complications Associated With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2017; 64(4): 639 doi: 10.1097/MPG.0000000000001492
15
Alessandro Sartini, Stefano Gitto, Marcello Bianchini, Maria Chiara Verga, Maria Di Girolamo, Angela Bertani, Mariagrazia Del Buono, Filippo Schepis, Barbara Lei, Nicola De Maria, Erica Villa. Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0124-2
16
Kishor Pant, Senthil K. Venugopal, Maria J. Lorenzo Pisarello, Sergio A. Gradilone. The Role of Gut Microbiome-Derived Short-Chain Fatty Acid Butyrate in Hepatobiliary Diseases. The American Journal of Pathology 2023; 193(10): 1455 doi: 10.1016/j.ajpath.2023.06.007
17
UEG Week 2018 Poster Presentations. United European Gastroenterology Journal 2018; 6(S8) doi: 10.1177/2050640618792819
18
Joshua B. French, Maurizio Bonacini, Marwan Ghabril, David Foureau, Herbert L. Bonkovsky. Hepatotoxicity Associated with the Use of Anti-TNF-α Agents. Drug Safety 2016; 39(3): 199 doi: 10.1007/s40264-015-0366-9
19
María Hernández-Tejero, Alicia Granja Navacerrada, Pilar Bernal Checa, Rubén Piqué Becerra, Alicia Algaba García, Iván Guerra Marina, Francisco Javier García-Alonso, Mariano Syed , Fernando Bermejo . Prevalence, risk factors and response to treatment of extra-intestinal manifestations in patients with inflammatory bowel disease. Revista Española de Enfermedades Digestivas 2017; 109 doi: 10.17235/reed.2017.4845/2017
20
Virginia Solitano, Antonio Moschetta. Metabolic Dysfunction–Associated Steatotic Liver Disease in Inflammatory Bowel Disease: A Proposed Stepwise Approach. Clinical Gastroenterology and Hepatology 2024; 22(2): 215 doi: 10.1016/j.cgh.2023.08.019
21
Torsten Schröder, Klaus J. Schmidt, Vera Olsen, Steffen Möller, Tilo Mackenroth, Christian Sina, Hendrik Lehnert, Klaus Fellermann, Jürgen Büning. Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment. European Journal of Gastroenterology & Hepatology 2015; 27(6): 698 doi: 10.1097/MEG.0000000000000350
22
Roberta E. Rossi, Dario Conte, Sara Massironi. Primary sclerosing cholangitis associated with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2016; 28(2): 123 doi: 10.1097/MEG.0000000000000532
23
Juliana Silva, Beatriz S. Brito, Isaac Neri de N. Silva, Viviane G. Nóbrega, Maria Carolina S. M. da Silva, Hemerson Dyego de N. Gomes, Flora Maria Fortes, Andrea M. Pimentel, Jaciane Mota, Neogélia Almeida, Valdiana C. Surlo, André Lyra, Raquel Rocha, Genoile O. Santana. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7604939
24
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
25
Eltaib Saad, Mohamed Agab, Emre Can Ozcekirdek, Abdalaziz Awadelkarim, Isra Idris. The Diagnostic Dilemma of Acute Granulomatous Hepatitis in a Patient With Crohn’s Disease: A Case Report and Review of Literature. Journal of Investigative Medicine High Impact Case Reports 2022; 10: 232470962110697 doi: 10.1177/23247096211069764
26
Rita Modesto, João Estarreja, Inês Silva, João Rocha, Rui Pinto, Vanessa Mateus. Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review. Journal of Clinical Medicine 2022; 11(10): 2739 doi: 10.3390/jcm11102739
27
Maria Angeles Aller, Javier Blanco-Rivero, Ana Arias, Jaime Arias. Translational Studies on Inflammation. 2020;  doi: 10.5772/intechopen.84689
28
Alireza Beheshti Maal, Mohammad Amin Shahrbaf, Bahareh Sadri, Nikoo Hossein-Khannazer, Mohammad Ali Mansournia, Massoud Vosough. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients. Journal of Crohn's and Colitis 2024; 18(3): 360 doi: 10.1093/ecco-jcc/jjad157
29
Qi Lv, Juan Wang, Hongqiong Yang, Xueli Chen, Yishu Zhang, Guangye Ji, Lihong Hu, Yinan Zhang. Didymin ameliorates ulcerative colitis-associated secondary liver damage by facilitating Notch1 degradation. Phytomedicine 2024; : 155561 doi: 10.1016/j.phymed.2024.155561
30
Matthias Pinter, Bernhard Scheiner, Markus Peck-Radosavljevic. Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups. Gut 2021; 70(1): 204 doi: 10.1136/gutjnl-2020-321702
31
Saraswathi Lakkasani, Gowthami Sai Kogilathota Jagirdhar, Murad Qirem, Scott W Digiacomo, Srinivasa Pantula. A Rare Case of Primary Sclerosing Cholangitis Overlapped With Autoimmune Hepatitis and Ulcerative Colitis. Cureus 2023;  doi: 10.7759/cureus.43403
32
Ersilia M. DeFilippis, Sonal Kumar. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2015; 60(10): 2873 doi: 10.1007/s10620-015-3699-4
33
Mafalda Sousa, Luísa Proença, João Carlos Silva, Ana Catarina Ribeiro Gomes, Edgar Afeto, João Carvalho. Duodenal Crohn’s Disease Complicated by Pancreatitis and Common Bile Duct Obstruction. GE - Portuguese Journal of Gastroenterology 2020; 27(1): 33 doi: 10.1159/000499767
34
Paulina Núñez F, Fabiola Castro, Gabriel Mezzano, Rodrigo Quera, Diego Diaz, Lorena Castro. Hepatobiliary manifestations in inflammatory bowel disease: A practical approach. World Journal of Hepatology 2022; 14(2): 319-337 doi: 10.4254/wjh.v14.i2.319
35
T. J. Weismüller, C. P. Strassburg. Primär sklerosierende Cholangitis. Der Gastroenterologe 2016; 11(4): 268 doi: 10.1007/s11377-016-0085-5
36
Peter L. Labib, George Goodchild, Stephen P. Pereira. Molecular Pathogenesis of Cholangiocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5391-0
37
Katerina Karaivazoglou, Christos Konstantakis, Evanthia Tourkochristou, Stelios F. Assimakopoulos, Christos Triantos. Non-alcoholic fatty liver disease in inflammatory bowel disease patients. European Journal of Gastroenterology & Hepatology 2020; 32(8): 903 doi: 10.1097/MEG.0000000000001679
38
Tamer A A M Habeeb, Abdulzahra Hussain, Mauro Podda, Pasquale Cianci, Bruce Ramshaw, Khaled Safwat, Wesam M Amr, Tamer Wasefy, Alaa A Fiad, Mohamed Ibrahim Mansour, Adel Mahmoud Moursi, Gamal Osman, Anass Qasem, Mohamed Fawzy, Mohamed Ibrahim Abo Alsaad, Abd-Elfattah Kalmoush, Mohammed Shaaban Nassar, Fawzy M Mustafa, Mahmoud Hassib Morsi Badawy, Ahmed Hamdy, Hamdi Elbelkasi, Bassam Mousa, Abd-Elrahman M Metwalli, Walid A Mawla, Mostafa M Elaidy, Muhammad Ali Baghdadi, Ahmed Raafat. Hepatobiliary manifestations following two-stages elective laparoscopic restorative proctocolectomy for patients with ulcerative colitis: A prospective observational study. World Journal of Gastrointestinal Surgery 2023; 15(2): 234-248 doi: 10.4240/wjgs.v15.i2.234
39
Talat Bessissow, Ngoc Han Le, Kathleen Rollet, Waqqas Afif, Alain Bitton, Giada Sebastiani. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(8): 1937 doi: 10.1097/MIB.0000000000000832
40
Salvatore Petta, Luca Valenti, Elisabetta Bugianesi, Giovanni Targher, Stefano Bellentani, Ferruccio Bonino, Ele Ferrannini, Carmela Loguercio, Amedeo Lonardo, Fabio Marra, Marcello Mancini, Luca Miele, Valerio Nobili, Gianluca Svegliati Baroni, Federico Alessandro, Stefano Ballestri, Maurizia Rossana Brunetto, Barbara Coco, Antonio Grieco, Silvia Fargion, Loreta Kondili, Fabio Nascimbeni, Anna Prinster, Dante Romagnoli, Stefano Taddei, Ester Vanni, Stefano Vella. A “systems medicine” approach to the study of non-alcoholic fatty liver disease. Digestive and Liver Disease 2016; 48(3): 333 doi: 10.1016/j.dld.2015.10.027
41
Timothy Hadley, Scott Gillespie, Hillary Espinoza, Jarod Prince, Henning Gronbaek, Shanmuganathan Chandrakasan, Subra Kuguthasan, Vasantha L. Kolachala, Nitika A. Gupta. Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease. Autoimmunity 2020; 53(5): 253 doi: 10.1080/08916934.2020.1755964
42
Luoyi Zhu, Xin Zong, Xiao Xiao, Yuanzhi Cheng, Jie Fu, Zeqing Lu, Mingliang Jin, Fengqin Wang, Yizhen Wang. Multi-Omics Analysis of the Gut-Liver Axis Reveals the Mechanism of Liver Injury in Colitis Mice. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.773070
43
Somtochukwu Onwuzo, Antoine Boustany, Mustafa Saleh, Riya Gupta, Chidera Onwuzo, Jessy Mascarenhas Monteiro, Favour Lawrence, Chukwuemeka Obuekwe, Zoya Morani, Imad Asaad. Increased Risk of Non-Alcoholic Steatohepatitis in Patients With Inflammatory Bowel Disease: A Population-Based Study. Cureus 2023;  doi: 10.7759/cureus.35854
44
Scott B. Raymond, Michael S. Gee, Sudha A. Anupindi, Randheer Shailam, Jess L. Kaplan, Katherine Nimkin. CT and MRI of Rare Extraintestinal Manifestations of Inflammatory Bowel Disease in Children and Adolescents. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(1) doi: 10.1097/MPG.0000000000001225
45
Chungho Lee, SangAh Kim, Bobae Kim, Wilhelm H. Holzapfel, Chang-Kee Hyun, Nobuyuki Takahashi. Disturbance of lipid metabolism in germ-free mice transplanted with gut microbiota of DSS-induced colitis mice. PLOS ONE 2023; 18(2): e0280850 doi: 10.1371/journal.pone.0280850
46
Xian-sen Jiang, Bi-le Fu, Xin-xin Yang, Hong-yan Qin. TNF-α Mediated the Disruption of Hepatic Tight Junction Expression in Blood–Biliary Barrier of Colitis <i>via</i> Downregulating PI3K/AKT Signaling Pathway. Biological and Pharmaceutical Bulletin 2023; 46(12): 1769 doi: 10.1248/bpb.b23-00503
47
João Sabino, Joren tenHove, Joana Torres. Biomarkers in Inflammatory Bowel Diseases. 2019; : 191 doi: 10.1007/978-3-030-11446-6_16
48
Alicia Algaba, Iván Guerra, Elena Ricart, Eva Iglesias, Miriam Mañosa, Javier P. Gisbert, Jordi Guardiola, Miguel Mínguez, Beatriz Castro, Ruth de Francisco, Pilar Nos, Federico Bertoletti, Francisco Mesonero, Jesús Barrio, María Dolores Martín-Arranz, Xavier Calvet, Santiago García-López, Beatriz Sicilia, Gillermo Alcaín, María Esteve, Lucía Márquez, Marta Piqueras, Laura Jiménez, José L. Perez-Calle, Luis Bujanda, Mariana García-Sepulcre, Alejandra Fernández, Irene Moraleja, Rufo Humberto Lorente, Orlando García-Bosch, Ana Lambán, Isabel Blázquez, Esther Rodríguez, José M. Huguet, Alfredo J. Lucendo, Pedro Almela, David Busquets, Patricia Ramírez de la Piscina, Marcela Pérez, Eugeni Domenech, Fernando Bermejo. Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry. Digestive Diseases and Sciences 2021; 66(6): 2014 doi: 10.1007/s10620-020-06424-x
49
Asama Lekbua, Jodie Ouahed, Amy E. O'Connell, Stacy A. Kahn, Jeffrey D. Goldsmith, Toshihiko Imamura, Christine N. Duncan, Judith R. Kelsen, Elizabeth Worthey, Scott B. Snapper, Samir Softic. Risk‐factors Associated With Poor Outcomes in VEO‐IBD Secondary to XIAP Deficiency. Journal of Pediatric Gastroenterology and Nutrition 2019; 69(1) doi: 10.1097/MPG.0000000000002297
50
Mortada HF El-Shabrawi, Sara Tarek, Maha Abou-Zekri, Safa Meshaal, Afaf Enayet, Engy Adel Mogahed. Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country. World Journal of Gastrointestinal Pharmacology and Therapeutics 2020; 11(3): 48-58 doi: 10.4292/wjgpt.v11.i3.48
51
Sabrina Cardile, Tommaso Alterio, Manila Candusso, Andrea Pietrobattista, Daniela Liccardo, Maria Sole Basso, Bronislava Papadatou, Fiammetta Bracci, Daniela Knafelz, Giuliano Torre. Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 662 doi: 10.1080/00365521.2017.1298833
52
Lukáš Bajer, Pavel Wohl, Pavel Drastich. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitis. Vnitřní lékařství 2018; 64(6): 659 doi: 10.36290/vnl.2018.090
53
Peter Jensen, Alexander Egeberg, Gunnar Gislason, Peter R. Hansen, Jacob P. Thyssen, Lone Skov. Increased Risk of Autoimmune Hepatitis in Patients with Psoriasis: A Danish Nationwide Cohort Study. Journal of Investigative Dermatology 2016; 136(7): 1515 doi: 10.1016/j.jid.2016.02.812
54
Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis. Journal of Clinical Medicine 2019; 8(10): 1574 doi: 10.3390/jcm8101574
55
Carolina Palmela, Farhad Peerani, Daniel Castaneda, Joana Torres, Steven H. Itzkowitz. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Gut and Liver 2018; 12(1): 17 doi: 10.5009/gnl16510
56
Еxtraintestinal manifestations of inflammatory bowel disease. Actual problems of modern medicine 2020; (5) doi: 10.26565/2617-409X-2020-5-08
57
Lixia Zan, Wenyi Zhang, Shufeng Shang, Yuanyuan Cui, Jinjin Pei, Yahong Yuan, Tianli Yue. Alleviating effect of selenium-enriched Lactobacillus plantarum 6076 on dextran sulfate sodium-induced colitis and liver inflammation in mice. Food & Function 2023; 14(22): 10151 doi: 10.1039/D3FO03842D
58
Alisha M. Mavis, Estella M. Alonso. Liver Disease in the Adolescent. Clinics in Liver Disease 2015; 19(1): 171 doi: 10.1016/j.cld.2014.09.010
59
Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel, Victoria Villena. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach. World Journal of Gastroenterology 2021; 27(41): 7113-7124 doi: 10.3748/wjg.v27.i41.7113
60
Alida Ainouche, Carole Durot, Philippe Soyer, Reza Kianmanesh, Sébastien Mulé, Christine Hoeffel. Unusual intestinal and extra intestinal findings in Crohn's disease seen on abdominal computed tomography and magnetic resonance enterography. Clinical Imaging 2020; 59(1): 30 doi: 10.1016/j.clinimag.2019.04.010
61
Dominika Suchecka, Joanna Harasym, Jacek Wilczak, Joanna Gromadzka-Ostrowska. Hepato- and gastro- protective activity of purified oat 1–3, 1–4-β- d -glucans of different molecular weight. International Journal of Biological Macromolecules 2016; 91: 1177 doi: 10.1016/j.ijbiomac.2016.06.062
62
Claudia-Gabriela Potcovaru, Petruța Violeta Filip, Oana-Maria Neagu, Laura Sorina Diaconu, Teodor Salmen, Delia Cinteză, Anca Pantea Stoian, Florin Bobirca, Mihai Berteanu, Corina Pop. Diagnostic Criteria and Prognostic Relevance of Sarcopenia in Patients with Inflammatory Bowel Disease—A Systematic Review. Journal of Clinical Medicine 2023; 12(14): 4713 doi: 10.3390/jcm12144713
63
Shikib Mostamand, Shauna Schroeder, Jacqueline Schenkein, Tamir Miloh. Infliximab‐Associated Immunomediated Hepatitis in Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(1): 94 doi: 10.1097/MPG.0000000000001137
64
Daniel F. Castillo, Ricardo Caicedo, Vani Gopalareddy. Liver Abscess in a Pediatric Patient with Ulcerative Colitis: A Case Presentation. Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2018.00045
65
Gadour Eyad, Hassan Zeinab. Systematic review and meta-analysis of drug induced liver injury secondary to biologic medications in inflammatory bowel disease. Annals of Clinical Gastroenterology and Hepatology 2021; 5(1): 005 doi: 10.29328/journal.acgh.1001025
66
Eun Jung Park, Seung Hyuk Baik. Atlas of Inflammatory Bowel Diseases. 2015; : 201 doi: 10.1007/978-3-642-39423-2_14
67
Erietta Polychronopoulou, Vasiliki Lygoura, Nikolaos K Gatselis, George N Dalekos. Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis. BMJ Case Reports 2017; : bcr-2017-220824 doi: 10.1136/bcr-2017-220824
68
Mohamed A. Abd El Aziz, Antonio Facciorusso, Tarek Nayfeh, Samer Saadi, Mohamed Elnaggar, Christian Cotsoglou, Rodolfo Sacco. Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma. Vaccines 2020; 8(4): 616 doi: 10.3390/vaccines8040616
69
Gang Liu, Alan W. Baird, Marie J. Parsons, Kening Fan, David A. Skerrett‐Byrne, Prema M. Nair, Samwel Makanyengo, Jinbiao Chen, Rachel Neal, Bridie J. Goggins, Hock Tay, Andrea Mathe, Wai S. Soh, Kyra Minahan, Phil M. Hansbro, Brett Nixon, Geoffrey W. McCaughan, Gerald Holtmann, Sean P. Colgan, Simon Keely. Platelet activating factor receptor acts to limit colitis‐induced liver inflammation. The FASEB Journal 2020; 34(6): 7718 doi: 10.1096/fj.201901779R
70
Minna Chang, Liisa Chang, Hanna M. Chang, Fuju Chang. Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease. Clinical Colorectal Cancer 2018; 17(1): e29 doi: 10.1016/j.clcc.2017.06.009
71
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Maria Rendina. Liver involvement in inflammatory bowel disease: What should the clinician know?. World Journal of Hepatology 2021; 13(11): 1534-1551 doi: 10.4254/wjh.v13.i11.1534
72
Gege Hu, Shaoli Liu, Hong Zeng, Ruokun Yi, Xin Zhao, Zhennai Yang. Prevention of dextran sulfate sodium (DSS)-induced ulcerative colitis in mice by a synbiotic approach using probiotic and lactulose. Letters in Applied Microbiology 2023; 76(5) doi: 10.1093/lambio/ovad057
73
Katharina Brandl, Bernd Schnabl. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?. Expert Review of Gastroenterology & Hepatology 2015; 9(8): 1069 doi: 10.1586/17474124.2015.1057122
74
Chowdhury F Zaman, Jakia Sultana, Proma Dey, Jui Dutta, Sadia Mustarin, Nuzhat Tamanna, Aditi Roy, Nisha Bhowmick, Mousumi Khanam, Sadia Sultana, Selia Chowdhury, Farjana Khanam, Md Sakibuzzaman, Priyata Dutta. A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022;  doi: 10.7759/cureus.29657
75
Aryashree Arunima, Jugal Kishore Das, Mrutyunjay Suar. Dietary Interventions in Gastrointestinal Diseases. 2019; : 117 doi: 10.1016/B978-0-12-814468-8.00010-7
76
Gary C. Kanel. Atlas of Liver Pathology. 2024; : 488 doi: 10.1016/B978-0-323-82533-7.00014-4
77
Valérie Heron, Kyle Joshua Fortinsky, Gillian Spiegle, Nir Hilzenrat, Andrew Szilagyi. Resected Hepatocellular Carcinoma in a Patient with Crohn’s Disease on Azathioprine. Case Reports in Gastroenterology 2016; 10(1): 54 doi: 10.1159/000444012
78
Vanessa Mateus, João Rocha, Paula Alves, Helder Mota‐Filipe, Bruno Sepodes, Rui Manuel Amaro Pinto. Anti‐Inflammatory Effect of Erythropoietin in the TNBS‐induced Colitis. Basic & Clinical Pharmacology & Toxicology 2017; 120(2): 138 doi: 10.1111/bcpt.12663
79
Jennifer Phillips, Rebecca Preskey, Chris Penfold, Fiona Gordon, Jonathan Tyrrell-Price. Liver steatosis is a risk factor for hepatotoxicity in inflammatory bowel disease patients treated with azathioprine. European Journal of Gastroenterology & Hepatology 2020; 32(10): 1390 doi: 10.1097/MEG.0000000000001683
80
Bogdan Ioannis Patedakis Litvinov, Amit P Pathak. Granulomatous hepatitis in a patient with Crohn's disease and cholestasis. BMJ Case Reports 2017; : bcr-2017-220988 doi: 10.1136/bcr-2017-220988
81
Sophie Restellini, Olivier Chazouillères, Jean‐Louis Frossard. Hepatic manifestations of inflammatory bowel diseases. Liver International 2017; 37(4): 475 doi: 10.1111/liv.13265
82
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver manifestations and complications in inflammatory bowel disease: A review. World Journal of Hepatology 2021; 13(12): 1956-1967 doi: 10.4254/wjh.v13.i12.1956
83
Ashley A. Bochenek. Inflammatory Bowel Disease. Clinical Gastroenterology 2017; : 319 doi: 10.1007/978-3-319-53763-4_19
84
Tatsuya Suzuki, Yuka Hayakawa, Shun Kaneko, Kento Takenaka, Keiya Watakabe, Yuko Kinowaki, Akira Takemoto, Kazuo Ohtsuka, Yasuhiro Asahina, Ryuichi Okamoto. Granulomatous hepatitis with Crohn’s disease: a case report. Clinical Journal of Gastroenterology 2024;  doi: 10.1007/s12328-024-01937-8
85
Scott D. Lee, Raina Shivashankar, Daniel Quirk, Haiying Zhang, Jean-Baptiste Telliez, John Andrews, Amy Marren, Arnab Mukherjee, Edward V. Loftus. Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments. Journal of Clinical Gastroenterology 2021; 55(3): 195 doi: 10.1097/MCG.0000000000001396
86
Henrique C. Rocha, Eduardo G. Vilela. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases. Gastroenterología y Hepatología 2022; 45(2): 83 doi: 10.1016/j.gastrohep.2021.03.011
87
Adil S. MIR, Dario SORRENTINO. Non-cirrhotic portal hypertension in inflammatory bowel disease. Minerva Gastroenterology 2023; 69(2) doi: 10.23736/S2724-5985.20.02684-7
88
Zhi Zhong, John J. Lemasters. A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease. Alcoholism: Clinical and Experimental Research 2018; 42(11): 2072 doi: 10.1111/acer.13877
89
Min Kyu Kang, Kyeong Ok Kim, Min Cheol Kim, Jung Gil Park, Byung Ik Jang. Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease. Digestive Diseases 2020; 38(6): 507 doi: 10.1159/000506938
90
Tarek Debs, Isabella Reccia, Imad El-Hajj, Ziad El-Rassi. Cholangiocarcinoma in Patients with Crohn’s Disease. Journal of Cancer Therapy 2015; 6(01): 21 doi: 10.4236/jct.2015.61003
91
Qianqian Yao, Yanan Gao, Linlin Fan, Jiaqi Wang, Nan Zheng. 2′-Fucosyllactose Remits Colitis-Induced Liver Oxygen Stress through the Gut–Liver–Metabolites Axis. Nutrients 2022; 14(19): 4186 doi: 10.3390/nu14194186
92
Mahmoud Mahfouz, Paul Martin, Andres F. Carrion. Hepatic Complications of Inflammatory Bowel Disease. Clinics in Liver Disease 2019; 23(2): 191 doi: 10.1016/j.cld.2018.12.003
93
Kerri Glassner, Hoda M. Malaty, Bincy P. Abraham. Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2017; 23(6): 998 doi: 10.1097/MIB.0000000000001085
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345